Jump to content
UK HealthCare CECentral
Search
Open menu
Cart
Register
Login
Bookmark/Search this post
Facebook
X
LinkedIn
Forward
Home
Courses
Enduring
Live Events
Series
Resources
About Us
Contact Us
Frequently Asked Questions
You are here
Home
»
Systematic Uptake and Standardization of...
»
SUSTAIN 3: Cytokine Release Syndrome...
Ayman Qasrawi, MD
Financial relationships
Attribution:
Other
Type of financial relationship:
Other
Ineligible company:
Sanofi
Topic:
Consultation Panel for cGVHD
Date added:
03/20/2026
Date updated:
06/01/2026
Relationship end date:
06/01/2025
Return to SUSTAIN 3: Cytokine Release Syndrome—Pathophysiology, Recognition, and Management
Search
Home
Courses
Enduring
Live Events
Series
Resources
About Us
Contact Us
Frequently Asked Questions